CLB
Core Laboratories Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$15.77
-0.13 ▼ -0.82%
🌙 3월 13일 6:23 PM ET (한국 3/14 07:23)
$15.77
+0.00 +0.00%
| Index | RUT | P/E | 23.41 | EPS (ttm) | 0.67 | Insider Own | 1.7% | Shs Outstand | 0.05B | Perf Week | -0.88% |
| Market Cap | 0.73B | Forward P/E | 18.39 | EPS next Y | 10.11% | Insider Trans | - | Shs Float | 0.05B | Perf Month | -16.74% |
| Enterprise Value | 0.88B | PEG | - | EPS next Q | 0.13 | Inst Own | 108.17% | Short Float | 9.45% | Perf Quarter | -7.34% |
| Income | 0.03B | P/S | 1.39 | EPS this Y | 3.86% | Inst Trans | -2.23% | Short Ratio | 11.21 | Perf Half Y | 24.47% |
| Sales | 0.53B | P/B | 2.68 | EPS next 5Y | - | ROA | 5.36% | Short Interest | 4.33M | Perf YTD | -1.62% |
| Book/sh | 5.89 | P/C | 32.14 | EPS past 3/5Y | 17.44% - | ROE | 11.96% | 52W High | -22.54% ($20.36) | Perf Year | 7.28% |
| Cash/sh | 0.49 | P/FCF | 31.53 | Sales past 3/5Y | 2.44% 1.56% | ROIC | 7.36% | 52W Low | 62.24% ($9.72) | Perf 3Y | -26.17% |
| Dividend Est. | $0.04 (0.25%) | EV/EBITDA | 13.88 | EPS Y/Y TTM | 6.34% | Gross Margin | 17.91% | Volatility(W/M) | 4.4% 4.56% | Perf 5Y | -57.9% |
| Dividend TTM | 0.04 | EV/Sales | 1.67 | Sales Y/Y TTM | 0.51% | Oper. Margin | 9.28% | ATR (14) | 0.77 | Perf 10Y | -86.57% |
| Dividend Ex-Date | 2026/2/13 | Quick Ratio | 1.57 | EPS Q/Q | -3.23% | Profit Margin | 6.04% | RSI (14) | 30.17 | Recom | 4 |
| Dividend Gr. 3/5Y | - -32.24% | Current Ratio | 2.07 | Sales Q/Q | 6.98% | SMA20 | -8.5% ($17.23) | Beta | 1.19 | Target Price | $16.75 |
| Payout | 5.88% | Debt/Eq | 0.59 | Earnings | 2000000 | SMA50 | -13.46% ($18.22) | Rel Volume | 1.01 | Prev Close | $15.9 |
| Employees | 3500 | LT Debt/Eq | 0.55 | EPS/Sales Surpr. | 9.83% 4.63% | SMA200 | 10.07% ($14.33) | Avg Volume(3M) | 0.39M | Price | $15.77 |
| IPO | 1995/9/21 | Option/Short | Yes/Yes | Trades | 5676 | Volume | 388,944 | Change | -0.82% |
뉴스 로딩 중...